Theriva Biologics, Inc. (TOVX)

Theriva Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	7	7	36	8	9
Market Cap Growth	-23.86%	1.72%	-79.95%	369.37%	-10.11%	12.82%
Enterprise Value	-12	-14	-33	-30	2	-6
PE Ratio	-	-0.40	-0.36	-1.55	-0.61	-0.53
PB Ratio	0.13	0.20	0.14	0.55	-1.61	4.68
P/FCF Ratio	-0.44	-0.38	-0.38	-2.79	-0.63	-0.61
P/OCF Ratio	-0.44	-0.39	-0.38	-2.79	-0.63	-0.61
EV/EBITDA Ratio	0.42	0.71	1.58	2.11	-0.19	0.39
EV/EBIT Ratio	0.41	0.69	1.56	2.09	-0.19	0.38
EV/FCF Ratio	0.45	0.72	1.72	2.31	-0.16	0.42
Debt / Equity Ratio	0.06	0.06	0.03	0.02	-0.10	0.40
Debt / EBITDA Ratio	-0.10	-0.11	-0.08	-0.11	-0.05	-0.05
Debt / FCF Ratio	-0.11	-0.11	-0.09	-0.12	-0.04	-0.05
Quick Ratio	3.06	3.45	5.93	18.94	2.10	2.85
Current Ratio	3.60	4.07	6.45	19.38	2.68	3.11
Return on Equity (ROE)	-49.30%	-42.90%	-33.80%	-31.50%	315.80%	-212.30%
Return on Assets (ROA)	-33.00%	-29.30%	-24.90%	-30.70%	-135.50%	-72.60%
Return on Capital (ROIC)	-64.80%	-54.79%	-40.33%	-21.33%	236.61%	-615.93%
Earnings Yield	-479.06%	-250.32%	-277.90%	-64.52%	-163.98%	-188.70%
FCF Yield	-464.57%	-261.91%	-266.42%	-35.90%	-159.02%	-162.84%
Buyback Yield / Dilution	-13.38%	-5.09%	-25.76%	-541.06%	-15.65%	-163.75%
Total Shareholder Return	-13.38%	-5.09%	-25.76%	-541.06%	-15.65%	-163.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).